Viewing StudyNCT06402331



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06402331
Status: RECRUITING
Last Update Posted: 2024-06-24
First Post: 2024-04-26

Brief Title: FPI-2265 225Ac-PSMA-IT for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer mCRPC
Sponsor: Fusion Pharmaceuticals Inc
Organization: Fusion Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Metastatic Castration-resistant Prostate Cancer
Keywords:
Name View
mCRPC View
225Ac-PSMA-IT View
Radioligand therapy View